Senate Markup Would Give NCI $985 Million, Offers Prospect That Reductions In Grants Will Be Restored
In Brief: Kennedy To Stay On Health Committee; Animal Research Bills Probably Dead For This Congress
Senate Committee Blocks Effort To Overturn Organ Systems Changes
New NCAB Weak In Grant Reviews, Confused By Issues
Final Issues Of 1982
Announcement, RFA On Drug Discovery Groups Coming
Steiner To Leave ICC, Says Someone Else May Do Better
NCI Buys Building For PDQ, ICRDB With Donated Money
Trending Stories
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater - She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- Scaling excellence: How City of Hope is transforming cancer care delivery
- First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI
